Low-dose external beam radiotherapy has highest failure rate in prostate cancer

In a study comparing biochemical failure rates of popular treatments for localized prostate cancer, low-dose external beam radiotherapy showed the highest failure rate.

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!

Related Videos

Sandip Prasad, MD, on the approval of mitomycin intravesical solution for LG-IR-NMIBC

Jennifer Robles, MD, discusses the growing interest in HoLEP

Suzanne Merrill, MD, on the rationale for BCG plus PD-1/PD-L1 inhibitors in high-risk NMIBC

Recent Content

FDA grants priority review to gepotidacin for uncomplicated urogenital gonorrhea

Pearls & Perspectives: Bringing the Magic Back to Medicine, with David Canes, MD

Perioperative EV plus pembrolizumab significantly extends EFS, OS in MIBC

Health Canada approves perioperative durvalumab plus chemo for MIBC

View More Recent Content

Do not sell my Personnal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Low-dose external beam radiotherapy has highest failure rate in prostate cancer

Newsletter